Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 08:41 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,921,579 8.4% | 498,724 (+14.57%) | View |
| 2022-02-10 1:29 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORP STT | 2,368,040 5.07% | 2,368,040 (New Position) | View |
| 2022-02-10 09:15 am Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 650,000 1.39% | -1,850,000 (-74.00%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | VANGUARD GROUP INC | 2,413,056 5.17% | 2,413,056 (New Position) | View |
| 2022-02-09 09:11 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | FMR LLC | 6,999,580 14.999% | 1,384,247 (+24.65%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | BlackRock Inc. BLK | 3,101,030 6.6% | 3,101,030 (New Position) | View |
| 2022-01-18 4:28 pm Unchanged | 13G | CELLDEX THERAPEUTICS, INC CLDX | Cowen Financial Products LLC | 0 0% | 0 (Unchanged) | View |
| 2022-01-14 1:29 pm Sale | 13G | CELLDEX THERAPEUTICS, INC CLDX | Cowen Financial Products LLC | 0 0% | -2,015,513 (Position Closed) | View |
| 2021-10-12 09:25 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | FMR LLC | 5,615,333 12.08% | 5,615,333 (New Position) | View |
| 2021-02-25 3:50 pm Purchase | 13G | CELLDEX THERAPEUTICS, INC CLDX | Cowen Financial Products LLC | 2,015,513 5.094% | 2,015,513 (New Position) | View |
| 2021-02-16 4:07 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Redmile Group LLC | 2,711,616 6.9% | 2,711,616 (New Position) | View |
| 2021-02-12 4:32 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | Ikarian Capital LLC | 1,364,990 3.5% | -227,449 (-14.28%) | View |
| 2021-02-12 09:52 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,422,855 8.66% | 1,537,855 (+81.58%) | View |
| 2021-02-11 4:33 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,740,000 (Position Closed) | View |
| 2021-02-11 07:39 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 6.32% | 600,000 (+31.58%) | View |
| 2021-02-10 4:51 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | RENAISSANCE TECHNOLOGIES LLC | 1,048,827 2.65% | -66,541 (-5.97%) | View |
| 2020-10-22 12:27 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Logos Global Management LP | 1,700,000 4.3% | 1,700,000 (New Position) | View |
| 2020-07-24 4:05 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,900,000 5.01% | 1,900,000 (New Position) | View |
| 2020-06-26 5:28 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | BIOTECHNOLOGY VALUE FUND L P | 2,740,000 7.2% | 2,740,000 (New Position) | View |
| 2020-06-19 10:36 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 1,885,000 9.95% | 1,885,000 (New Position) | View |